FLGT FY 2022 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$619M-37.6% YoY

Gross Profit

$367M59.3% margin

Operating Income

$179M28.8% margin

Net Income

$143M23.2% margin

EPS (Diluted)

$4.63

Cash Flow

Operating Cash Flow

$254M

Free Cash Flow

$235M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$116M

Stockholders' Equity

$1.3B

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$619M	$993M	-37.6%
Gross Profit	$367M	$777M	-52.8%
Operating Income	$179M	$676M	-73.6%
Net Income	$143M	$507M	-71.7%